Back
Supernus Pharmaceuticals Vs. United Therapeutics Industry Stock Comparison
Sell
48
SUPN
Supernus Pharmaceuticals
Last Price:
36.57
Seasonality Move:
5.14%
Buy
67
UTHR
United Therapeutics
Last Price:
410.82
Seasonality Move:
4.71%
Sell
48
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $36.61. The Score for SUPN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $410.00. The Score for UTHR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $36.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $410.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight selling pressure.
SUPN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | 309767 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.58 - 35.38) | Buy |
| Bollinger Bands (100): | (28.66 - 34.48) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.4 | Buy |
| Relative Strength Index (14 RSI): | 78.95 | Buy |
| Chaikin Money Flow: | -40036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (349.7 - 383) | Buy |
| Bollinger Bands (100): | (323.27 - 363.95) | Buy |
SUPN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.41 | Buy |
| 20-day SMA: | 34.44 | Buy |
| 50-day SMA: | 33.16 | Buy |
| 200-day SMA: | 30.69 | Buy |
| 8-day EMA: | 35.66 | Buy |
| 20-day EMA: | 34.59 | Buy |
| 50-day EMA: | 33.37 | Buy |
| 200-day EMA: | 31.24 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 384.82 | Buy |
| 20-day SMA: | 369.33 | Buy |
| 50-day SMA: | 358.93 | Buy |
| 200-day SMA: | 293.58 | Buy |
| 8-day EMA: | 388.19 | Buy |
| 20-day EMA: | 373.83 | Buy |
| 50-day EMA: | 359.57 | Buy |
| 200-day EMA: | 309.5 | Buy |
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Supernus Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||